Results 241 to 250 of about 1,015,424 (347)

The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy. [PDF]

Biochem Med (Zagreb), 2021
Lapić I, Lončar Vrančić A, Coen Herak D, Rogić D.   +3 more
europepmc   +1 more source

Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction—a paradigmatic case report [PDF]

, 2016
Giovanni Poli, Piero Castiglioni, Martina Montagnana, Emmanuel J. Favaloro, Giuseppe Lippi   +4 more
openalex   +1 more source

Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support.

JACC. Heart failure, 2015
S. Adatya, N. Uriel, H. Yarmohammadi, Christopher T. Holley, Amy Feng, S. Roy, M. Reding, R. John, P. Eckman, N. Zantek   +9 more
semanticscholar   +1 more source

Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma. [PDF]

Cureus, 2022
Patil P, Sehgal T, Goswami P, Gaur M, Khan M, Pandey S, Datta SK.   +6 more
europepmc   +1 more source

An experimental comparison and user evaluation of three different dried plasma products

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Access to blood components in pre‐hospital bleeding resuscitation is challenging. Dried plasma is a logistically superior alternative, and new products are emerging. Therefore, we aimed to evaluate laboratory and practical differences in three differently produced dried plasma products.
Kristina Ehn, Gabriel Skallsjö, Birgitta Romlin, Göran Sandström, Per Sandgren, Agneta Wikman   +5 more
wiley   +1 more source

Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis. [PDF]

BMC Pregnancy Childbirth
Alemayehu E, Mohammed O, Belete MA, Mulatie Z, Debash H, Gedefie A, Weldehanna DG, Eshetu B, Shibabaw A, Tekele SG, Tilahun M, Ebrahim H.   +11 more
europepmc   +1 more source

A Recurrent Neural Network Model for Predicting Activated Partial Thromboplastin Time After Treatment With Heparin: Retrospective Study.

JMIR Med Inform, 2022
Boie SD, Engelhardt LJ, Coenen N, Giesa N, Rubarth K, Menk M, Balzer F.   +6 more
europepmc   +1 more source

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models. [PDF]

Front Vet Sci, 2022
De Pablo-Moreno JA, Liras A, Revuelta L.
europepmc   +1 more source

Rapid Enoxaparin Adjustment for Childhood Thrombosis/Thromboprophylaxis

Pediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT Enoxaparin dosing in children is imperfect and strategies to optimize initial therapy for patients at high‐thrombotic risk would be of clinical benefit. This study looked at using peak‐post‐first‐enoxaparin‐dose anti‐Xa to guide subsequent enoxaparin dose and timing of administration in children deemed high‐thrombotic risk.
Joel Livingston, Leanne Meakins, Aisha Bruce, David Stammers, Catherine Corriveau‐Bourque, Anna Serebrin, Kerry Wong, Mary Bauman   +7 more
wiley   +1 more source

Rare Prekallikrein Deficiency Identified During Workup of Isolated Prolonged Activated Partial Thromboplastin Time. [PDF]

Ochsner J
Woo JS, Tseng J, Kang IM, Zhuang L, Jackson R, Danilova OV, Borogovac A.   +6 more
europepmc   +1 more source